A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
Top Cited Papers
- 1 December 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology
- Vol. 73 (22) , 1914-1922
- https://doi.org/10.1212/wnl.0b013e3181c47cc2
Abstract
There is a long history of research into body fluid biomarkers in neurodegenerative and neuroinflammatory diseases. However, only a few biomarkers in CSF are being used in clinical practice. One of the most critical factors in CSF biomarker research is the inadequate powering of studies because of the lack of sufficient samples that can be obtained in single-center studies. Therefore, collaboration between investigators is needed to establish large biobanks of well-defined samples. Standardized protocols for biobanking are a prerequisite to ensure that the statistical power gained by increasing the numbers of CSF samples is not compromised by preanalytical factors. Here, a consensus report on recommendations for CSF collection and biobanking is presented, formed by the BioMS-eu network for CSF biomarker research in multiple sclerosis. We focus on CSF collection procedures, preanalytical factors, and high-quality clinical and paraclinical information. The biobanking protocols are applicable for CSF biobanks for research targeting any neurologic disease.This publication has 48 references indexed in Scilit:
- Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working GroupJournal of Proteome Research, 2008
- Pre‐analytical influence on the low molecular weight cerebrospinal fluid proteomeProteomics – Clinical Applications, 2007
- Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variationcclm, 2007
- Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the ratLife Sciences, 2006
- Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier‐mediated epitope masking of amyloid β peptidesElectrophoresis, 2004
- Cognitive dysfunction in multiple sclerosis: a review of recent developmentsCurrent Opinion in Neurology, 2003
- Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosisMultiple Sclerosis Journal, 1998
- Defining the clinical course of multiple sclerosisNeurology, 1996
- CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisoloneActa Neurologica Scandinavica, 1992
- Rating neurologic impairment in multiple sclerosisNeurology, 1983